Brian C. Gilmour, PhD

Research Fellow
University of Oslo, Norway

Poster(s):

• Th140 - SH2D2A Is an Indicator of Favourable Prognosis in Bladder Cancer and Is Enriched in Activated Treg Cells
  Thursday, June 20, 2024

  7:30 AM – 7:45 PM PT